
Enpp-1-IN-16
CAS No. 2289739-47-3
Enpp-1-IN-16( —— )
Catalog No. M37145 CAS No. 2289739-47-3
Enpp-1-IN-16 is an inhibitor targeting ENPP1 with potential anti-cancer activity.Enpp-1-IN-16 can be used to study insulin resistance in relation to type II diabetes mellitus and various ENPP1-mediated diseases in the chondrocalcinosis and osteoarthritis classes.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 76 | Get Quote |
![]() ![]() |
10MG | 122 | Get Quote |
![]() ![]() |
25MG | 266 | Get Quote |
![]() ![]() |
50MG | 419 | Get Quote |
![]() ![]() |
100MG | 647 | Get Quote |
![]() ![]() |
500MG | 1341 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameEnpp-1-IN-16
-
NoteResearch use only, not for human use.
-
Brief DescriptionEnpp-1-IN-16 is an inhibitor targeting ENPP1 with potential anti-cancer activity.Enpp-1-IN-16 can be used to study insulin resistance in relation to type II diabetes mellitus and various ENPP1-mediated diseases in the chondrocalcinosis and osteoarthritis classes.
-
DescriptionEnpp-1-IN-16 (compound 54) is an ENPP1 inhibitor. Enpp-1-IN-16 has the potential to study cancer, especially in cases of high ENPP1 expression or elevated cytoplasmic DNA levels. Enpp-1-IN-16 can also be used in other diseases mediated by ENPP1, such as bacterial or viral infections, insulin resistance and type II diabetes, chondrocalcinosis and osteoarthritis, calcium pyrophosphate deposition disorder (CPPD), low Phosphatase disease and soft tissue calcification disorders.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2289739-47-3
-
Formula Weight428.52
-
Molecular FormulaC23H32N4O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 2 mg/mL (4.67 mM; Ultrasonic )
-
SMILESO=C(OC(C)(C)C)N1CCC2(C1)CCN(C=3N=CN=C4C=C(OC)C(OC)=CC43)CC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Derek A Cogan, et al. Imino sulfanone inhibitors of enpp1. WO2021225969A1.
molnova catalog



related products
-
Zaprinast
Zaprinast (M&B 22948) is a potent, cGMP-specific phosphodiesterase inhibitor with IC50 of 0.5-0.76 and 0.15 uM for PDE5 and PDE6 respectively.
-
PF-03049423
PF-03049423 is a potent, selective, orally active, and brain penetrant inhibitor of PDE5 with IC50 of 0.2 nM.
-
Vardenafil
Vardenafil (Levitra) is an oral therapy for the treatment of erectile dysfunction.